Learn more about whether ADMA Biologics, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

Capricor Therapeutics met with the FDA last week for a type A meeting, during which CEO Linda Marbán aimed to explain to the ...

Frustration is reportedly mounting inside the Trump administration as senior officials grow increasingly suspicious of right‑wing provocateur Laura Loomer, with some branding her as “more trouble than ...

The FDA said data for PTC's drug did not prove "substantial evidence of efficacy." Elsewhere, the FDA delayed its decision on ...

Elliott Management is now one of Medtronic's biggest investors. Here's how the activist investor is shaking things up.

Preliminary data are expected this year for a Phase 1/2 clinical trial testing the investigational therapy SRP-1003 in DM1.